Effect of bisoprolol combination with perindopril and spironolactone on chronic heart failure caused by rheumatic heart disease

VernacularTitle:比索洛尔联合培哚普利、螺内酯治疗风湿性心脏病慢性心力衰竭的效果观察
Author: Leyan CAI ; Xingfeng XIA
Publication Type:Journal Article
Keywords: Rheumatic heart disease; Chronic heart failure; Perindopril; Bisoprolol; Spironolactone
From: Chinese Journal of Primary Medicine and Pharmacy 2016;23(8):1240-1243
CountryChina
Language:Chinese
Abstract: Objective To evaluate the combination treatment effects of bisoprolol,perindopril and spirono-lactone on chronic cardiac failure caused by rheumatic heart disease.Methods 92 patients were randomly divided into the control group (n=45) and observation group (n=47).The observation group received combination usage of bisoprolol,perindopril and spironolactone,while the control group was given regular treatment.Cardiac functions were measured in both two groups.Results The left ventricular end diastolic diameter ( LVEDD) and left ventricular end systolic diameter (LVESD) were significantly decreased in the observation group(t=4.217,5.842,P<0.05),while left ventricular ejection fraction (LVEF) was significantly increased compared with the control group (t=3.164,P<0.05).Conclusion The combination treatment effects of bisoprolol,perindopril and spironolactone has the privilege effects on chronic cardiac failure caused by rheumatic heart disease,which mainly improves cardiac remodeling.